285 related articles for article (PubMed ID: 18794558)
1. Proton-pump inhibitor use and the risk for community-acquired pneumonia.
Sarkar M; Hennessy S; Yang YX
Ann Intern Med; 2008 Sep; 149(6):391-8. PubMed ID: 18794558
[TBL] [Abstract][Full Text] [Related]
2. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
[TBL] [Abstract][Full Text] [Related]
3. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
[TBL] [Abstract][Full Text] [Related]
4. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
Giuliano C; Wilhelm SM; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
[TBL] [Abstract][Full Text] [Related]
5. Long-term proton pump inhibitor therapy and risk of hip fracture.
Yang YX; Lewis JD; Epstein S; Metz DC
JAMA; 2006 Dec; 296(24):2947-53. PubMed ID: 17190895
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
[TBL] [Abstract][Full Text] [Related]
7. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB
JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580
[TBL] [Abstract][Full Text] [Related]
8. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
[TBL] [Abstract][Full Text] [Related]
9. Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults.
Zirk-Sadowski J; Masoli JA; Delgado J; Hamilton W; Strain WD; Henley W; Melzer D; Ble A
J Am Geriatr Soc; 2018 Jul; 66(7):1332-1338. PubMed ID: 29676433
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy and the risk for community-acquired pneumonia.
Gau JT; Acharya U; Khan S; Heh V; Mody L; Kao TC
BMC Geriatr; 2010 Jul; 10():45. PubMed ID: 20604960
[TBL] [Abstract][Full Text] [Related]
11. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis.
Filion KB; Chateau D; Targownik LE; Gershon A; Durand M; Tamim H; Teare GF; Ravani P; Ernst P; Dormuth CR;
Gut; 2014 Apr; 63(4):552-8. PubMed ID: 23856153
[TBL] [Abstract][Full Text] [Related]
13. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.
Gulmez SE; Holm A; Frederiksen H; Jensen TG; Pedersen C; Hallas J
Arch Intern Med; 2007 May; 167(9):950-5. PubMed ID: 17502537
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
[TBL] [Abstract][Full Text] [Related]
15. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.
Lambert AA; Lam JO; Paik JJ; Ugarte-Gil C; Drummond MB; Crowell TA
PLoS One; 2015; 10(6):e0128004. PubMed ID: 26042842
[TBL] [Abstract][Full Text] [Related]
16. Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study.
Chatterjee S; Carnahan RM; Chen H; Holmes HM; Johnson ML; Aparasu RR
J Am Geriatr Soc; 2016 Feb; 64(2):394-400. PubMed ID: 26889844
[TBL] [Abstract][Full Text] [Related]
17. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
Myles PR; Hubbard RB; McKeever TM; Pogson Z; Smith CJ; Gibson JE
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):269-75. PubMed ID: 19235776
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.
Johnstone J; Nerenberg K; Loeb M
Aliment Pharmacol Ther; 2010 Jun; 31(11):1165-77. PubMed ID: 20222914
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitors and Infant Pneumonia/Other Lower Respiratory Tract Infections: National Nested Case-control Study.
Blank ML; Parkin L; Zeng J; Barson D
J Pediatr Gastroenterol Nutr; 2018 Sep; 67(3):335-340. PubMed ID: 29601438
[TBL] [Abstract][Full Text] [Related]
20. Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: An Updated Meta-analysis.
Xun X; Yin Q; Fu Y; He X; Dong Z
Ann Pharmacother; 2022 May; 56(5):524-532. PubMed ID: 34425689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
